SCHEMBL18201318

SCHEMBL18201318

O=P(c1ccccc1)(c1ccccc1)c1cccc(-c2nc3ccccc3c3c2cc(-c2ccc(-c4cn5ccccc5n4)cc2)c2ccccc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 11/20 0.41
▸ RAB9A P51151 10/20 0.41
▸ SMN1; SMN2 Q16637 6/20 0.41
▸ POLB P06746 4/20 0.41
▸ GFER P55789 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ MAPT P10636 3/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ NPC1 O15118 8/20 0.40
▸ ALDH1A1 P00352 7/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ BACE2 Q9Y5Z0 1/20 0.40
▸ ALDH1A2 O94788 1/20 0.40
▸ ALDH1A3 P47895 1/20 0.40
▸ CASP3 P42574 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200919 0.85 RAB9A (0.45) KDM4ERAB9ASMN1; SMN2POLBGFER
SCHEMBL18200657 0.83 BACE1 (0.43) KDM4ERAB9ASMN1; SMN2POLBGFER
SCHEMBL18200933 0.83 BACE1 (0.45) KDM4ERAB9ASMN1; SMN2POLBGFER
SCHEMBL18201316 0.83 TOP1 (0.39) KDM4ESMN1; SMN2LMNAMAPTMAPK1
SCHEMBL18200603 0.83 TOP1 (0.39) KDM4ESMN1; SMN2LMNAMAPTMAPK1
SCHEMBL17035173 0.81 DHODH (0.42) KDM4ERAB9ALMNAMAPK1NPC1
SCHEMBL18200659 0.80 BACE1 (0.46) KDM4ERAB9ASMN1; SMN2POLBGFER
SCHEMBL17034970 0.80 DHODH (0.37) KDM4ELMNAMAPTNPSR1ALDH1A1
SCHEMBL18346972 0.80 TOP1 (0.36) MAPTALDH1A1
SCHEMBL21934585 0.79 RAB9A (0.49) KDM4ERAB9ASMN1; SMN2POLBGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 — — US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 — — US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 — — US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 KDM4E 1977/4885RAB9A 2864/4885SMN1; SMN2 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback